RSS
29 Oct 2020

Field Trip Health Ltd. Provides Update on FT-104, Its Next Generation Psychedelic Molecule in Development

Author: admintech | Filed under: Press Release

Results confirm that Field Trip’s novel psychedelic molecule is similar in potency to psilocybin but with shorter duration of psychoactivity making it a potentially preferable option for psychedelic therapies TORONTO, Oct. 29, 2020 /PRNewswire/ — Field Trip Health Ltd. (CSE: FTRP) (OTC:…

This entry was posted on Thursday, October 29th, 2020 at 7:18 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»